Key facts
- Listed location
New Haven, Connecticut, USA
- Company type
- Manufacturer
- Company size
- Medium (50-500)
- Founded
- 1998
Company record
Achillion Pharmaceuticals, Inc. develops investigational compounds intended for use in pharmaceutical research and clinical trials, focusing on the creation of both protease and polymerase inhibitors.
Listed capabilities
- Radium & Radium Compounds
- Enzyme Inhibitors
- Polymerization Inhibitors
Similar companies
This directory record does not yet have a linked material-flow brief.